[1] ANSARI N, SIMS NA. The cells of bone and their interactions. Handb Exp Pharmacol. 2020;262:1-25.
[2] KONDO N, KURODA T, KOBAYASHI D. Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci. 2021;22(20):10922.
[3] JANG D, LEE A, SHIN H, et al. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci. 2021;22(5):2719.
[4] KITAURA H, MARAHLEH A, OHORI F, et al. Role of the interaction of tumor necrosis factor-α and tumor necrosis factor receptors 1 and 2 in bone-related cells. Int J Mol Sci. 2022;23(3):1481.
[5] IDRESS M, MILNE BF, THOMPSON GS, et al. Structure-based design, synthesis and bioactivity of a new anti-TNFα cyclopeptide. Molecules. 2020;25(4):922.
[6] YONGYUN C, JINGWEI Z, ZHIQING L, et al. Andrographolide stimulates osteoblastogenesis and bone formation by inhibiting nuclear factor kappa-Β signaling both in vivo and in vitro. J Orthop Translat. 2019;19:47-57.
[7] DONSANTE S, PALMISANO B, SERAFINI M, et al. From stem cells to bone-forming cells. Int J Mol Sci. 2021;22(8):3989.
[8] EVANS CE, JONES S. Soluble factors secreted by macrophage-like cells in vitro cause osteoprogenitor cell detachment. Calcif Tissue Int. 1998,63(6):496-504.
[9] GERSTENFELD LC, CHO TJ, KON T, et al. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs. 2001;169(3):285-294.
[10] HARBOUR ME, GREGORY JW, JENKINS HR, et al. Proliferative response of different human osteoblast-like cell models to proinflammatory cytokines. Pediatr Res. 2000;48(2):163-168.
[11] LEE S, SHARMA AR, CHOI B, et al. The effect of TNFα secreted from macrophages activated by titanium particles on osteogenic activity regulated by WNT/BMP signaling in osteoprogenitor cells. Biomaterials. 2012;33(17):4251-4263.
[12] ZHANG L, HADDOUTI EM, WELLE K, et al. The effects of biomaterial implant wear debris on osteoblasts. Front Cell Dev Biol. 2020;8:352.
[13] BEN DAVID D, REZNICK AZ, SROUJI S, et al. Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors. Histochem Cell Biol. 2008;129(5):589-597.
[14] LIU H, LI D, ZHANG Y, et al. Inflammation, mesenchymal stem cells and bone regeneration. Histochem Cell Biol. 2018;149(4):393-404.
[15] BEN-DAVID D, LIVNE E, REZNICK AZ. The involvement of oxidants and NF-kappaB in cytokine-induced MMP-9 synthesis by bone marrow-derived osteoprogenitor cells. Inflamm Res. 2012;61(7):673-688.
[16] GUO H, ZHANG J, HAO S, et al. Adenovirus-mediated small interfering RNA targeting tumor necrosis factor-α inhibits titanium particle-induced osteoclastogenesis and bone resorption. Int J Mol Med. 2013;32(2):296-306.
[17] SUN Y, LI J, XIE X, et al. Macrophage-osteoclast associations: origin, polarization, and subgroups. Front Immunol. 2021;12:778078.
[18] BORGHI A, VERSTREPEN L, BEYAERT R. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death. Biochem Pharmacol. 2016;116:1-10.
[19] YAO Z, GETTING SJ, LOCKE IC. Regulation of TNF-induced osteoclast differentiation. Cells. 2021;11(1):132.
[20] PARK H, BAEK K, BAEK J, et al. TNFα increases RANKL expression via PGE2-induced activation of NFATc1. Int J Mol Sci. 2017;18(3):495.
[21] YOU K, GU H, YUAN Z, et al. Tumor necrosis factor alpha signaling and organogenesis. Front Cell Dev Biol. 2021;9:727075.
[22] MUKAI T, OTSUKA F, OTANI H, et al. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun. 2007;356(4):1004-1010.
[23] ISLAM S, HASSAN F, TUMURKHUU G, et al. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells. Biochem Biophys Res Commun. 2007;360(2):346-351.
[24] SADEK KM, EL MS, RADWAN IA, et al. Molecular basis beyond interrelated bone resorption/regeneration in periodontal diseases: a concise review. Int J Mol Sci. 2023;24(5):4599.
[25] ALFORD PB, XUE Y, SHACKELFORD RE. Tumor necrosis factor-alpha induces c-fms RNA expression in murine tissue macrophages. Biochem Biophys Res Commun. 1997;240(2):442-445.
[26] KITAURA H, SANDS MS, AYA K, et al. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-α-induced osteoclastogenesis in vivo. J Immunol. 2004;173(8):4838.
[27] MARAHLEH A, KITAURA H, OHORI F, et al. Effect of TNF-α on osteocyte RANKL expression during orthodontic tooth movement. J Dent Sci. 2021;16(4):1191-1197.
[28] OGAWA S, KITAURA H, KISHIKAWA A, et al. TNF-α is responsible for the contribution of stromal cells to osteoclast and odontoclast formation during orthodontic tooth movement. PLoS One. 2019;14(10):e223989.
[29] ZOU W, AMCHESLAVSKY A, TAKESHITA S, et al. TNF-α expression is transcriptionally regulated by RANK ligand. J Cell Physiol. 2005;202(2):371-378.
[30] KITAURA H, ZHOU P, KIM H, et al. M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest. 2005;115(12):3418-3427.
[31] HU X, YIN Z, CHEN X, et al. Tussilagone inhibits osteoclastogenesis and periprosthetic osteolysis by suppressing the NF-κB and P38 MAPK signaling pathways. Front Pharmacol. 2020;11:385.
[32] STARLINGER J, SARAHRUDI K, KECHT M, et al. The influence of M-CSF on fracture healing in a mouse model. Sci Rep. 2021;11(1):22326.
[33] MEYER A, PARMAR PJ, SHAHRARA S. Significance of IL-7 and IL-7R in RA and autoimmunity. Autoimmun Rev. 2022;21(7):103120.
[34] KIM JH, SIM JH, LEE S, et al. Interleukin-7 induces osteoclast formation via STAT5, independent of receptor activator of NF-kappaB ligand. Front Immunol. 2017;8:1376.
[35] KOBAYASHI K, TAKAHASHI N, JIMI E, et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med. 2000;191(2):275-286.
[36] KIM N, KADONO Y, TAKAMI M, et al. Osteoclast differentiation independent of the TRANCE–RANK–TRAF6 axis. J Exp Med. 2005;202(5):589-595.
[37] O’BRIEN W, FISSEL BM, MAEDA Y, et al. RANK-independent osteoclast formation and bone erosion in inflammatory arthritis. Arthritis Rheumatol. 2016;68(12): 2889-2900.
[38] MIZOGUCHI T, ONO N. The diverse origin of bone-forming osteoblasts. J Bone Miner Res. 2021;36(8):1432-1447.
[39] GILBERT LC, RUBIN J, NANES MS. The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. Am J Physiol Endocrinol Metab. 2005;288(5):E1011-E1018.
[40] TARTAGLIA LA, PENNICA D, GOEDDEL D . Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem. 1993;268(25):18542-18548.
[41] SETHI JK, HOTAMISLIGIL GS. Metabolic messengers: tumour necrosis factor. Nat Metab. 2021;3(10):1302-1312.
[42] BRENNER D, BLASER H, MAK TW. Regulation of tumour necrosis factor signalling:live or let die. Nat Rev Immunol. 2015;15(6):362-374.
[43] PESCATORE A, CASALE C, FUSCO F, et al. Methods to study the effect of IKK inhibition on TNF-inducing apoptosis and necroptosis in cultured cells. Methods Mol Biol. 2021;2366:243-254.
[44] MCMILLAN D, MARTINEZ-FLEITES C, PORTER J, et al. Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF. Nat Commun. 2021;12(1):582.
[45] KOMORI T. Regulation of proliferation, differentiation and functions of osteoblasts by Runx2. Int J Mol Sci. 2019;20(7):1694.
[46] KIM H, KIM W, RYOO H. Post-translational regulations of transcriptional activity of RUNX2. Molecules and Cells. 2020;43(2):160-167.
[47] GILBERT L, HE X, FARMER P, et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2αA) is inhibited by tumor necrosis factor-α. J Biol Chem. 2002;277(4):2695-2701.
[48] 韩耀伦,王璐,马欣.ERK1/2-Runx2信号通路在TNF-α对牙周膜干细胞成骨分化影响中的作用[J].中国免疫学杂志,2019;35(21):2587-2592.
[49] CHANG J, LIU F, LEE M, et al. NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation. Proc Natl Acad Sci U S A. 2013;110(23):9469-9474.
[50] LI W, LIU Q, SHI J, et al. The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment. Front Immunol. 2023;14:1074863.
[51] CHOU LY, HO CT, HUNG SC. Paracrine senescence of mesenchymal stromal cells involves inflammatory cytokines and the NF-κB pathway. Cells. 2022;11(20):3324.
[52] ELISEEV R, SCHWARZ E, ZUSCIK M, et al. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFκB. Exp Cell Res. 2006;312(1):40-50.
[53] LI W, YU B, LI M, et al. NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha. Biochem Biophys Res Commun. 2010;391(2):1228-1233.
[54] LI X, YANG H, ZHANG Z, et al. Concentrated growth factor exudate enhances the proliferation of human periodontal ligament cells in the presence of TNF‑α. Mol Med Rep. 2019;19(2):943-950.
[55] WU WJ, XIA CL, OU SJ, et al. Prophylactic effects of NFκB essential modulator-binding domain peptides on bone infection:an experimental study in a rabbit model. J Inflamm Res. 2022;15:2745-2759.
[56] JIMI E. The role of BMP signaling and NF-kappaB signaling on osteoblastic differentiation, cancer development, and vascular diseases--is the activation of NF-kappaB a friend or foe of BMP function? Vitam Horm. 2015;99:145-170.
[57] ZHU WQ, MING PP, ZHANG SM, et al. Role of MAPK/JNK signaling pathway on the regulation of biological behaviors of MC3T3‑E1 osteoblasts under titanium ion exposure. Mol Med Rep. 2020;22(6):4792-4800.
[58] JILKA RL, WEINSTEIN RS, BELLIDO T, et al. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res. 1998;13(5):793-802.
[59] HAMEISTER R, LOHMANN CH, DHEEN ST, et al. The effect of TNF-α on osteoblasts in metal wear-induced periprosthetic bone loss. Bone Joint Res. 2020;9(11):827-839.
[60] LUTTRELL LM, DAR MS, GESTY-PALMER D, et al. Transcriptomic characterization of signaling pathways associated with osteoblastic differentiation of MC-3T3E1 cells. PLoS One. 2019;14(1):e204197.
[61] GHALI O, CHAUVEAU C, HARDOUIN P, et al. TNF-α’s effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression. J Bone and Miner Res. 2010;25(7):1616-1626.
[62] KOMORI T. Molecular mechanism of Runx2-dependent bone development. Mol Cells. 2020;43(2):168-175.
[63] 史方富,崔红旺,孙博.自噬在肿瘤坏死因子α诱导成骨细胞凋亡中的作用[J].临床骨科杂志,2021,24(4):601-604.
[64] XIAO L, XIAO Y. The Autophagy in osteoimmonology: self-eating, maintenance, and beyond. Front Endocrinol (Lausanne). 2019;10:490.
[65] SHI G, JIA P, CHEN H, et al. Necroptosis occurs in osteoblasts during tumor necrosis factor-α stimulation and caspase-8 inhibition. Braz J Med Biol Res. 2019; 52(1):e7844.
[66] HU X, WANG Z, KONG C, et al. Necroptosis: a new target for prevention of osteoporosis. Front Endocrinol (Lausanne). 2022;13:1032614.
[67] TRESGUERRES FGF, TORRES J, LÓPEZ-QUILES J, et al. The osteocyte:a multifunctional cell within the bone. Ann Anat. 2020;227:151422.
[68] MARAHLEH A, KITAURA H, OHORI F, et al. TNF-α directly enhances osteocyte RANKL expression and promotes osteoclast formation. Front Immunol. 2019; 10:2925.
[69] KITAURA H, MARAHLEH A, OHORI F, et al. Osteocyte-related cytokines regulate osteoclast formation and bone resorption. Int J Mol Sci. 2020;21(14):5169.
[70] PATHAK JL, BAKKER AD, LUYTEN FP, et al. Systemic inflammation affects human osteocyte-specific protein and cytokine expression. Calcif Tissue Int. 2016;98(6):596-608.
[71] RAUNER M, TAIPALEENMÄKI H, TSOURDI E, et al. Osteoporosis treatment with anti-sclerostin antibodies-mechanisms of action and clinical application. J Clin Med. 2021;10(4):787.
[72] TAN SD, KUIJPERS-JAGTMAN AM, SEMEINS CM, et al. Fluid shear stress inhibits tnfα-induced osteocyte apoptosis. J Dental Res. 2006;85(10):905-909.
[73] YAN Y, WANG L, GE L, et al. Osteocyte-mediated translation of mechanical stimuli to cellular signaling and its role in bone and non-bone-related clinical complications. Curr Osteoporos Rep. 2020;18(1):67-80.
[74] BAKKER AD, DA SILVA VC, KRISHNAN R, et al. Tumor necrosis factor α and interleukin-1β modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes. Arthritis Rheum. 2009;60(11):3336-3345.
[75] KOGIANNI G, MANN V, NOBLE BS. Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res. 2008;23(6):915-927.
[76] PLOTKIN LI, WEINSTEIN RS, PARFITT AM, et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999; 104(10):1363-1374.
[77] AHUJA SS, ZHAO S, BELLIDO T, et al. CD40 ligand blocks apoptosis induced by tumor necrosis factor α, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology. 2003; 144(5):1761-1769. |